ERCC6L2 and hemophagocytic syndrome: Genetic testing identified a homozygous pathogenic variant in <i>ERCC6L2</i> and a heterozygous <i>ADA2</i> variant, which we interpret as indicating a susceptibility background to immune dysregulation, with HLH most plausibly occurring as a secondary, trigger-dependent event.